Literature DB >> 23799980

Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study.

Gokhan Gungor1, Huseyin Ataseven, Ali Demir, Yalcin Solak, Abduzhappar Gaipov, Murat Biyik, Bahadir Ozturk, Ilker Polat, Aysel Kiyici, Ozlem O Cakir, Hakki Polat.   

Abstract

BACKGROUND & AIMS: Hepatorenal syndrome (HRS) is a severe complication of cirrhosis which is characterized by renal dysfunction and associated with poor survival. Neutrophil gelatinase-associated lipocalin (NGAL) is a troponin-like biomarker for human acute kidney injury. We aimed to investigate levels of plasma and urine NGAL in HRS and predictive ability of these markers for all-cause mortality, in HRS, stable cirrhosis and control subjects.
METHODS: A total of 64 patients with cirrhosis (8 patients with type 1 HRS, 22 with type 2 HRS, and 34 without HRS) and 23 control subjects were included in the study. Blood and urine samples were measured with Human NGAL sandwich ELISA. Patients were followed up prospectively.
RESULTS: Patients with type 1 and type 2 HRS had significantly higher plasma and urine NGAL levels compared with stable cirrhosis and control subjects. Cox regression analysis showed that plasma NGAL and MELD-Na scores were independent predictors of mortality. ROC-curve analysis showed that the plot of the plasma NGAL, urine NGAL, MELD-Na and Child-Turcot-Pugh score could predict all-cause mortality in cirrhotic patients' area under the curve (AUC 0.819, 0.686, 0.807 and 0.795 respectively).
CONCLUSIONS: NGAL could predict mortality in patients with HRS independent of other commonly used risk factors.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute kidney injury; cirrhosis; hepatorenal syndrome; mortality; neutrophil gelatinase-associated lipocalin

Mesh:

Substances:

Year:  2013        PMID: 23799980     DOI: 10.1111/liv.12232

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  17 in total

Review 1.  The role of neutrophils in the development of liver diseases.

Authors:  Ruonan Xu; Huihuang Huang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2014-03-17       Impact factor: 11.530

Review 2.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

Review 3.  Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.

Authors:  Jeremy Puthumana; Xavier Ariza; Justin M Belcher; Isabel Graupera; Pere Ginès; Chirag R Parikh
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

Review 4.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

5.  A decision support system for the prediction of mortality in patients with acute kidney injury admitted in intensive care unit.

Authors:  Selda Kayaalti; Omer Kayaalti; Bekir Hakan Aksebzeci
Journal:  J Appl Biomed       Date:  2020-02-28       Impact factor: 1.797

6.  Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

Authors:  Alessio Strazzulla; Giuseppe Coppolino; Concetta Di Fatta; Francesca Giancotti; Giuseppina D'Onofrio; Maria Concetta Postorino; Maria Mazzitelli; Selma Valerie Mammone; Innocenza Gentile; Laura Rivoli; Eleonora Palella; Tiziana Gravina; Chiara Costa; Vincenzo Pisani; Vincenzo De Maria; Giorgio Settimo Barreca; Nadia Marascio; Alfredo Focà; Giorgio Fuiano; Elio Gulletta; Carlo Torti
Journal:  World J Hepatol       Date:  2016-07-08

7.  Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.

Authors:  Sombat Treeprasertsuk; Amornpun Wongkarnjana; Veeravich Jaruvongvanich; Sasipim Sallapant; Khajohn Tiranathanagul; Piyawat Komolmit; Pisit Tangkijvanich
Journal:  BMC Gastroenterol       Date:  2015-10-16       Impact factor: 3.067

Review 8.  Renal dysfunction in cirrhosis is not just a vasomotor nephropathy.

Authors:  Danielle Adebayo; Vincenzo Morabito; Andrew Davenport; Rajiv Jalan
Journal:  Kidney Int       Date:  2014-10-08       Impact factor: 10.612

9.  Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients.

Authors:  Eugenia Singer; Eva V Schrezenmeier; Antje Elger; Evelyn R Seelow; Alexander Krannich; Friedrich C Luft; Kai M Schmidt-Ott
Journal:  Kidney Int Rep       Date:  2016-07-25

Review 10.  Neutrophil Gelatinase Associated Lipocalin (NGAL) - a biomarker of renal dysfunction in patients with liver cirrhosis: Do we have enough proof?

Authors:  S G Firu; C T Streba; D Firu; D E Tache; I Rogoveanu
Journal:  J Med Life       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.